$22.17
+0.01 (+0.05%)
Open$22.17
Previous Close$22.16
Day High$22.23
Day Low$21.90
52W High$22.50
52W Low$8.61
Volume—
Avg Volume548.2K
Market Cap144.18M
P/E Ratio—
EPS$-4.92
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+8.1% upside
Current
$22.17
$22.17
Target
$23.96
$23.96
$13.92
$23.96 avg
$25.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 120.57M | 132.12M | 46.50M |
| Net Income | -30,851,028 | -30,425,076 | 11.15M |
| Profit Margin | -25.6% | -24.3% | 24.0% |
| EBITDA | 159.3K | 165.9K | 17.15M |
| Free Cash Flow | — | — | 10.93M |
| Rev Growth | -8.7% | -8.7% | +24.8% |
| Debt/Equity | 0.42 | 0.42 | 0.73 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |